or
Bookmark and Share
5-Fluorouracil derivatives
   
Document Number
US Patent 3971784
Issued Date
July 27, 1976
Link
Inventors
Map
Abstract
5-Fluorouracil derivatives represented by the formula ##SPC1## Wherein R is arylcarbonyl, substituted arylcarbonyl, heterocyclic carbonyl, alkylsulfonyl, arylsulfonyl, substituted arylsulfonyl, heterocyclic sulfonyl or alicyclic sulfonyl are effective antimetabolites useful in mammary gland or gastrointestinal cancer therapy.
Drawing
5-Fluorouracil derivatives - US Patent 3971784 Drawing
Drawing from US Patent 3971784
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
27
Comments:
no comments yet
Published
July 27, 1976
Application Number
05/527,143
Filed
November 25, 1974
US Classification
544/310   544/313
Int'l Classification
C07D   239/00   (20060101)   C07D   239/54   (20060101)   C07D   239/553   (20060101)   A61K   31/505   (20060101)  
Attorney/Law Firm
Priority Data
Nov 28, 1973 [JA] 48-132795 Nov 28, 1973 [JA] 48-132796
USPTO Field of Search
260/260   260/256.5R  
Related Patents
4130648 - 5-Fluorouracil derivatives and antitumor preparations containing the same - Owned by Eisai Co., Ltd. (JP)

Novel 5-fluorouracil derivatives of the general formula: ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 each represent hydrogen atom or methyl group, and R.sub.4 represents a straight or branched alkyl or alkenyl group, which has low toxicity and improved antitumor activity, and novel antitumor preparations containing the said 5-fluorouracil derivative.

4088646 - 5-Fluorouracil derivatives - Owned by Asahi Kasei Kogyo Kabushiki Kaisha (Osaka,JA)

A compound represented by the formulae: ##STR1## wherein R.sub.1 and R.sub.2 are as defined hereinafter, useful as an anti-cancer or anti-tumor agent.

4528372 - N-Phthalidyl-5-fluorouracils - Owned by Grelan Pharmaceutical Co., Ltd. (Tokyo,JP)

The present invention relates to novel N-phthalidyl-5-fluorouracil derivatives represented by the general formula ##STR1## wherein one of R.sub.1 and R.sub.2 represents phthalidyl group ##STR2## (wherein R.sub.3 is a hydrogen atom, a halogen atom or a group selected from alkoxyl groups or alkyl groups) and the other represents a hydrogen atom, an acyl group or a cyclic ether group; ##STR3## (wherein n is 1 or 2) or R.sub.1 and R.sub.2 represent the same phthalidyl group; ##STR4## (wherein R.sub.3 has the same meaning as that defined above) and provides a compound which has antitumor activity and less toxicity and can be used as a cancerocidal agent.

6156894 - Process for manufacturing .alpha..sub. 1L-adrenoceptor antagonists - Owned by Hoffman-La Roche Inc. (Nutley, NJ)

A process is useful for making compounds of the formula: wherein R is hydro, methyl, or fluoro. Valuable intermediates in this process include: ##STR1## wherein R is hydro, methyl, or fluoro, and L is a leaving group.

4307098 - Pesticidal compositions and processes for treating plants - Owned by Imperial Chemical Industries Limited (London,GB2) Zoecon Corporation (Palo Alto, CA)

A method and pesticidal composition for the preventative, protectant, prophylactic and eradicant treatment of plant fungi and bacteria comprises applying an effective amount to plants or seeds of a pesticidal composition containing in an inert carrier a compound of the formula ##STR1## wherein R is hydrogen, methyl or ethyl; R.sup.1 is polyhaloalkyl or polyhalovinyl; R.sup.2 is lower alkyl, lower alkoxy, bromo, chloro, fluoro, lower haloalkyl, cyano, nitro, lower alkylthio, lower alkylcarbonyl, lower alkoxycarbonyl or cycloalkyl; R.sup.3 is hydrogen or independently selected from the values of R.sup.2 ; R.sup.4 is hydrogen or independently selected from the values of R.sup.2 ; X is hydrogen, carbamoyl or cyano; and y is zero, one or two.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us